Special Issue "Public Health Emergencies and Threats: From Vaccine Efficacy to Antimicrobial Resistance"
Deadline for manuscript submissions: 31 July 2022.
Interests: public health; infectious diseases; vaccination; vaccine hesitancy (VH); antimicrobial resistance (AMR); multidrug-resistant organisms (MDROs); communicable diseases
Interests: childhood nutrition and health; childhood obesity; child immunizations; vaccine-preventable diseases
Special Issues, Collections and Topics in MDPI journals
Special Issue in Vaccines: Vaccine Hesitancy and Child Immunizations: Rationales, Issues and Knowledge Gaps 2.0
Special Issue in International Journal of Environmental Research and Public Health: COVID-19 Pandemic and Children's Psychophysical Health: Issues and Challenges Ahead
The SARS-CoV-2 pandemic has highlighted how public health and global health research is now more crucial than ever. The WHO itself in 2019 listed both vaccine hesitancy and multidrug-resistant organisms, together with climate change and communicable diseases (HIV, Ebola, Dengue), among its 10 current threats to global health. 1.5 million lives could be saved each year by achieving optimal vaccination coverage, and even more worrying are the WHO predictions that in 2050 we could reach 10 million deaths/year due to antimicrobial resistance.
Given the need to increase scientific knowledge in these areas, in this Special Issue of Biologics we are inviting manuscripts on all aspects of public health emergencies and threats. These may be inherent to bacterial/viral vaccines (safety, efficacy, effectiveness, vaccine hesitancy/confidence) or antimicrobial resistance (diagnostics, therapies, surveillance, response) but not limited to these. The call is open to both research articles and reviews.
Dr. Marco Montalti
Prof. Dr. Davide Gori
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biologics is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- public health emergencies
- public health threats
- infectious diseases
- vaccine hesitancy (VH)
- antimicrobial resistance (AMR)
- multidrug-resistant organisms (MDROs)
- communicable diseases